On the three-arm non-inferiority trial including a placebo with a prespecified margin.

  title={On the three-arm non-inferiority trial including a placebo with a prespecified margin.},
  author={Eisuke Hida and Toshiro Tango},
  journal={Statistics in medicine},
  volume={30 3},
Three-arm trials including the experimental treatment, an active reference treatment and a placebo are recommended in the guidelines of the ICH and EMEA/CPMP as a useful approach to the assessment of assay sensitivity. Generally, the acceptable non-inferiority margin Δ has been defined as the maximum clinically irrelevant difference between treatments in many two-arm non-inferiority trials. However, many recent articles discussing three-arm trials have considered a design with unknown Δ which… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 12 extracted citations

Some practical considerations in three-arm non-inferiority trial design.

Pharmaceutical statistics • 2016
View 4 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 19 references

Randomized Controlled Trial (in Japanese)

T. Tango
Asakura Publishing: Tokyo, • 2003
View 5 Excerpts
Highly Influenced

Clinical evaluation of duloxetine in the treatment of major depressive disorder—placebo- and paroxetine-controlled double-blind comparative study

T Higuchi, M Murasaki, K. Kamijima
Japanese Journal of Clinical Psychopharmacology • 2009
View 3 Excerpts
Highly Influenced

Therapeutic equivalence investigations: statistical considerations.

Statistics in medicine • 1998
View 4 Excerpts
Highly Influenced

Noninferiority hypotheses and choice of noninferiority margin.

Statistics in medicine • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…